Your browser doesn't support javascript.
loading
Standardization of Good Manufacturing Practice-compliant production of bone marrow-derived human mesenchymal stromal cells for immunotherapeutic applications.
Wuchter, Patrick; Bieback, Karen; Schrezenmeier, Hubert; Bornhäuser, Martin; Müller, Lutz P; Bönig, Halvard; Wagner, Wolfgang; Meisel, Roland; Pavel, Petra; Tonn, Torsten; Lang, Peter; Müller, Ingo; Renner, Matthias; Malcherek, Georg; Saffrich, Rainer; Buss, Eike C; Horn, Patrick; Rojewski, Markus; Schmitt, Anita; Ho, Anthony D; Sanzenbacher, Ralf; Schmitt, Michael.
Afiliação
  • Wuchter P; Department of Medicine V, Heidelberg University, Heidelberg, Germany. Electronic address: patrick.wuchter@med.uni-heidelberg.de.
  • Bieback K; Institute of Transfusion Medicine and Immunology Mannheim, Medical Faculty Mannheim, Heidelberg University, German Red Cross Blood Donor Service Baden-Württemberg-Hessen, Mannheim, Germany.
  • Schrezenmeier H; Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University of Ulm, Ulm, Germany.
  • Bornhäuser M; Department of Internal Medicine I, University Hospital Carl Gustav Carus, Dresden, Germany.
  • Müller LP; Department of Medicine IV, University Hospital Halle (Saale), Halle (Saale), Germany.
  • Bönig H; Institute for Transfusion Medicine and Immunohematology, Goethe University, Frankfurt/Main and German Red Cross Blood Service Baden-Württemberg-Hessen, Frankfurt/Main, Germany.
  • Wagner W; Helmholtz Institute for Biomedical Technology, Stem Cell Biology and Cellular Engineering, University of Aachen Medical School, Aachen, Germany.
  • Meisel R; Division of Pediatric Stem Cell Therapy, Clinic for Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
  • Pavel P; Stem Cell Laboratory, IKTZ Heidelberg GmbH, Heidelberg, Germany.
  • Tonn T; Institute of Transfusion Medicine, Red Cross Blood Transfusion Service Dresden, Dresden, Germany.
  • Lang P; Department of Pediatrics, University Clinic Tübingen, Tübingen, Germany.
  • Müller I; Clinic for Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Renner M; Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Langen, Germany.
  • Malcherek G; Department of Medicine V, Heidelberg University, Heidelberg, Germany.
  • Saffrich R; Department of Medicine V, Heidelberg University, Heidelberg, Germany.
  • Buss EC; Department of Medicine V, Heidelberg University, Heidelberg, Germany.
  • Horn P; Department of Medicine V, Heidelberg University, Heidelberg, Germany.
  • Rojewski M; Institute for Clinical Transfusion Medicine and Immunogenetics Ulm, Red Cross Blood Transfusion Service Baden-Württemberg-Hessen and University of Ulm, Ulm, Germany.
  • Schmitt A; Department of Medicine V, Heidelberg University, Heidelberg, Germany.
  • Ho AD; Department of Medicine V, Heidelberg University, Heidelberg, Germany.
  • Sanzenbacher R; Paul-Ehrlich-Institut, Federal Institute for Vaccines and Biomedicines, Langen, Germany.
  • Schmitt M; Department of Medicine V, Heidelberg University, Heidelberg, Germany.
Cytotherapy ; 17(2): 128-39, 2015 Feb.
Article em En | MEDLINE | ID: mdl-24856898

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Fidelidade a Diretrizes / Células-Tronco Mesenquimais Tipo de estudo: Guideline Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Cytotherapy Assunto da revista: TERAPEUTICA Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Imunoterapia Adotiva / Fidelidade a Diretrizes / Células-Tronco Mesenquimais Tipo de estudo: Guideline Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Cytotherapy Assunto da revista: TERAPEUTICA Ano de publicação: 2015 Tipo de documento: Article